Cytosorbents Corp CTSO

Technology Scientific & Technical Instruments

CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. The Company’s blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its lead product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses that can lead to massive inflammation, organ failure and patient death. Its products also include ECOS-300CY, VetResQ, DrugSorb-ATR, and PuriFi. DrugSorb-ATR is an investigational device that uses equivalent polymer technology to CytoSorb to address a large unmet need for blood thinner reversal in cardiothoracic surgery. ECOS-300CY is used to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system.

NDAQ:CTSO - Post by User

Cytosorbents Corp

<< Previous

Bullboard Posts

(800)
•••

Comment by SouthernTierTomon Sep 15, 2018 11:49am

460 Views

Post# 28625998

RE:great future

Im already in and questioning the valuation. For a company valued well north of 500 M CAD, the scientific backing is looking as thin as a layer of frost on a September pumpkin.

<< Previous

Bullboard Posts

A Canadian mineral company at the crossroads of electrification and defense